ArticleFrontiers in oncology2023

Corrigendum: Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis.

Jun-Ning Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.